This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
13 Jan 2017  |  North America  |  Market Research
Global Pharmaceutical Stability Testing Market Trends, Opportunities, and Future
Consolidated Stability Storage is Leading to CROs Evolving into Development Partners and Driving the Stability Testing Outsourcing Market
This research service on the global pharmaceutical stability testing market addresses market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year is 2015 and forecasts are provided from 2016 to 2020. The market is expected to grow at a CAGR of 9.4% till 2020, driven by an explosio...
$1,500.00 -
11 Jan 2017  |  North America  |  Market Research
Global Cell Banking Market Trends, Opportunities, and Future
As Outsourcing of Cell Line Development Services Drives the Market, Contract Service Providers Focus on Providing End-to-end Services by Expanding the
This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020. The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by special...
$1,500.00 -
02 Jan 2017  |  North America  |  Market Research
Western European Molecular Diagnostics Market, 2015 Forecast to 2020
Prevalence and Prevention Driving Healthcare in Europe Toward Molecular Diagnostics Expansion and Innovation
Across the In vitro diagnostics Segment , including research and further upcoming disruptive technologies Across the Life Sciences landscape, including research tools, clinical diagnostics and pharma, disruptive technologies transform the complete the Healthcare decision making , and diagnostics trend . However, to take advantage of these opportun...
$4,950.00 -
11 Nov 2016  |  North America  |  Market Research
Global Orphan Drug Market
High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs
The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...
$6,000.00 -
08 Nov 2016  |  North America  |  Market Research
The US Molecular Diagnostics Market, Forecast to 2021
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
$4,950.00 -
13 Sep 2016  |  North America  |  Market Research
US Next-generation Sequencing Services Market
$1,000 Genome Pricing and Throughput to Drive More and Larger Sequencing Projects
The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation or third-generation platforms that use newer technology than traditional capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation tasks (i.e., library prep and target enrichment), and NGS-ba...
$4,950.00 -
25 Jul 2016  |  North America  |  Market Research
US Hospital Cybersecurity Market—2015–2021
Healthcare Gears Up to Combat the Growing Risk of Cyber Attacks
The report describes and defines the market for various types of solutions (products and services) deployed by US hospitals to protect the security of enterprise information technology (IT) systems and the privacy and security of patient information; covers key factors driving the need to deploy these solutions in response to dynamic industry shift...
$4,950.00 -
08 Jul 2016  |  North America  |  Market Research
Digital Health Grows Up- Is Pharma Guiding the Way?
Frost & Sullivan reviews key themes and industry trends from the 5th Annual Digital Health Summer Summit and BIO International held in June 2016. Major topics covered include the use of virtual and augmented reality in medical education and clinical care; new digital health technologies to improve mental health; investor perspectives on the market ...
$1,500.00 -
23 Jun 2016  |  North America  |  Market Research
Healthcare Wearables—5 Strategies to Avoid in Development
With regards to wearables and healthcare, strong customer demand and surging sales are only part of the story. The other side of the narrative captures the tale of a highly volatile marketplace where, due to intense competition, there is a revolving door of company entries and exits. Accordingly, Frost & Sullivan’s team, through its tracking of w...
$1,500.00 -
23 Jun 2016  |  North America  |  Market Research
Growth Opportunities in the US Point-of-care Testing Market
Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics
The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...
$4,950.00